Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids [clinicaltrials:NCT00100191]

Bio2RDF uri

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids [clinicaltrials:NCT00100191]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00100191

Bio2RDF identifier

NCT00100191

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00100191

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00100191

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:3b210bdeb29f01e0e61395f51dfc3e60

brief summary [clinicaltrials_vocabulary:brief-summary]

The Emmy trial is set u ...... l blood loss after treatment.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:093b063eba7677405406c7b53724dc94]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:15f9ba9895b3724b4ce54485bbabe010]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:3b51570d70b04c3a318855cbe19dc1b0]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:4f7dff6e5bef973b298cf68a988d6f06]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:66e0e13313ebd6827a2e746b6133b217]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:77d3c6f551b52d16a678c49974082824]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:7a7de75c53638f0f7b75e2014b009e5e]

The primary endpoint is the normalization of menorrhagia after a two-year follow-up period [clinicaltrials_resource:c4fdf91345123ded334843360a1729bb]

collaborator [clinicaltrials_vocabulary:collaborator]

ZonMw: The Netherlands Organisation for Health Research and Development [clinicaltrials_resource:cec04e14a842fbc8e9a0a2ad7163c71e]

completion date [clinicaltrials_vocabulary:completion-date]

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

Uterine Artery Emboliza ...... s, and quality of life.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00100191 [clinicaltrials_resource:08a959be1d698c1ef4ff7f1fc1828f8d]

enrollment [clinicaltrials_vocabulary:enrollment]

120

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2004-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

hysterectomy [clinicaltrials_resource:347df4adc44f7126296fd7c18cdab5b8]

uterine artery embolization [clinicaltrials_resource:582e686c036282c644a890e01ff47432]

keyword [clinicaltrials_vocabulary:keyword]

fibroids

http://www.w3.org/2001/XMLSchema#string

hysterectomy

http://www.w3.org/2001/XMLSchema#string

menorrhagia

http://www.w3.org/2001/XMLSchema#string

therapeutic embolization

http://www.w3.org/2001/XMLSchema#string

uterine artery embolization

http://www.w3.org/2001/XMLSchema#string

uterus

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2005-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

ZonMw: The Netherlands Organisation for Health Research and Development [clinicaltrials_resource:cec04e14a842fbc8e9a0a2ad7163c71e]

location [clinicaltrials_vocabulary:location]

27 Other Participating Hospitals of Varying Sizes Throughout the Country [clinicaltrials_resource:5949129a219a32ab4c6f365d9208351c]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00100191

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

EMMY Trial: a Randomized Compa ...... f Symptomatic Uterine Fibroids

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

NWO-DO 945-01-17

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

J.A. Reekers, MD, PhD [clinicaltrials_resource:3b1d553f530b804a3f1ee900112f8a07]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) [clinicaltrials_resource:a951f063ea181eb8b0e2d760be5ece4a]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

source [clinicaltrials_vocabulary:source]

ZonMw: The Netherlands Organisation for Health Research and Development [clinicaltrials_resource:cec04e14a842fbc8e9a0a2ad7163c71e]

start date [clinicaltrials_vocabulary:start-date]

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00100191 study design [clinicaltrials_resource:76b60142bf580ce7a8148b474245e398]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00100191

verification date [clinicaltrials_vocabulary:verification-date]

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00100191

http://www.w3.org/2001/XMLSchema#string

title

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Emmy Trial: Uterine Artery Emb ...... s [clinicaltrials:NCT00100191]

@en